NEW YORK (GenomeWeb) – Curetis has received CE-IVD marking for its multiplex PCR-based assay for severe intra-abdominal infections. The firm plans to launch the test at upcoming conferences in Europe.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.